Boston scientific eluvia™ drug-eluting vascular stent system exhibits superiority compared to bare metal stents

Las vegas and marlborough, mass., oct. 6, 2021 /prnewswire/ -- today, boston scientific corporation (nyse: bsx) announced positive data for the eluvia™ drug-eluting vascular stent system (eluvia stent) during a late-breaking clinical trial presentation at the vascular interventional advances (viva) meeting in las vegas.
BSX Ratings Summary
BSX Quant Ranking